MIR-27 Negatively Regulates Pluripotency-Associated Genes in Human Embryonal Carcinoma Cells

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Fuchs, Heiko ^a   Theuser, Matthias ^b   Wruck, Wasco ^a   Adjaye, James ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER RECEPTOR HOMOLOG 1; MICRORNA; MICRORNA 27A; MICRORNA 27B; OCTAMER TRANSCRIPTION FACTOR 4; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; WNT PROTEIN; ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR TYPE II-A; MIRN27 MICRORNA, HUMAN; POU5F1 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SMAD2 PROTEIN, HUMAN; SMALL INTERFERING RNA; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ACVR2A GENE; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; EMBRYONAL CARCINOMA; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LIN28B GENE; NANOG GENE; NR5A2 GENE; POLR3G GENE; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD2 GENE; TGFBR1 GENE; TRANSCRIPTOMICS; UPREGULATION; WNT SIGNALING PATHWAY; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; EMBRYONAL CARCINOMA STEM CELL; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; LIVER CELL; METABOLISM;

ACTIVIN RECEPTORS, TYPE II; CELL DIFFERENTIATION; CELL LINE; EMBRYONAL CARCINOMA STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEK293 CELLS; HEPATOCYTES; HUMANS; MICRORNAS; OCTAMER TRANSCRIPTION FACTOR-3; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; UP-REGULATION;

EID: 84920473926     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111637     Document Type: Article

References (64)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
2. Greber B, Lehrach H, Adjaye J (2007) Fibroblast growth factor 2 modulates transforming growth factor beta signaling in mouse embryonic fibroblasts and human ESCs (hESCs) to support hESC self-renewal. Stem Cells 25: 455-464.
3. Greber B, Lehrach H, Adjaye J (2007) Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for selfrenewal. BMC Dev Biol 7: 46.
4. Beattie GM, Lopez AD, Bucay N, Hinton A, Firpo MT, et al. (2005) Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23: 489-495.
5. Jiang J, Ng HH (2008) TGFbeta and SMADs talk to NANOG in human embryonic stem cells. Cell Stem Cell 3: 127-128.
6. Xu RH, Sampsell-Barron TL, Gu F, Root S, Peck RM, et al. (2008) NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 3: 196-206.
7. Sung B, Do HJ, Park SW, Huh SH, Oh JH, et al. (2012) Regulation of OCT4 gene expression by liver receptor homolog-1 in human embryonic carcinoma cells. Biochem Biophys Res Commun 427: 315-320.
8. Gu P, Goodwin B, Chung AC, Xu X, Wheeler DA, et al. (2005) Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development. Mol Cell Biol 25: 3492-3505.
9. Wang W, Yang J, Liu H, Lu D, Chen X, et al. (2011) Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc Natl Acad Sci U S A 108: 18283-18288.
10. Heng JC, Feng B, Han J, Jiang J, Kraus P, et al. (2010) The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 6: 167-174.
11. Wong RC, Pollan S, Fong H, Ibrahim A, Smith EL, et al. (2011) A novel role for an RNA polymerase III subunit POLR3G in regulating pluripotency in human embryonic stem cells. Stem Cells 29: 1517-1527.
12. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
13. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
14. Polesskaya A, Cuvellier S, Naguibneva I, Duquet A, Moss EG, et al. (2007) Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev 21: 1125-1138.
15. Qiu C, Ma Y, Wang J, Peng S, Huang Y (2010) Lin28-mediated posttranscriptional regulation of Oct4 expression in human embryonic stem cells. Nucleic Acids Res 38: 1240-1248.
16. Rybak A, Fuchs H, Smirnova L, Brandt C, Pohl EE, et al. (2008) A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol 10: 987-993.
17. Heo I, Joo C, Cho J, Ha M, Han J, et al. (2008) Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell 32: 276-284.
18. Ambros V (2001) microRNAs: Tiny regulators with great potential. Cell 107: 823-826.
19. Stadler B, Ivanovska I, Mehta K, Song S, Nelson A, et al. (2010) Characterization of microRNAs involved in embryonic stem cell states. Stem Cells Dev 19: 935-950.
20. Wilson KD, Venkatasubrahmanyam S, Jia F, Sun N, Butte AJ, et al. (2009) MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev 18: 749-758.
21. Card DA, Hebbar PB, Li L, Trotter KW, Komatsu Y, et al. (2008) Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 28: 6426-6438.
22. Kang H, Louie J, Weisman A, Sheu-Gruttadauria J, Davis-Dusenbery BN, et al. (2012) Inhibition of microRNA-302 (miR-302) by bone morphogenetic protein 4 (BMP4) facilitates the BMP signaling pathway. J Biol Chem 287: 38656-38664.
23. Mazda M, Nishi K, Naito Y, Ui-Tei K (2011) E-cadherin is transcriptionally activated via suppression of ZEB1 transcriptional repressor by small RNAmediated gene silencing. PLoS One 6: E28688.
24. Rosa A, Brivanlou AH (2011) A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation. EMBO J 30: 237-248.
25. Hu S, Wilson KD, Ghosh Z, Han L, Wang Y, et al. (2013) MicroRNA-302 Increases Reprogramming Efficiency via Repression of NR2F2. Stem Cells 31: 259-268.
26. Lee YS, Dutta A (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21: 1025-1030.
27. Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, et al. (2009) Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci U S A 106: 3384-3389.
28. Jain AK, Allton K, Iacovino M, Mahen E, Milczarek RJ, et al. (2012) p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol 10: E1001268.
29. Choi YJ, Lin CP, Ho JJ, He X, Okada N, et al. (2011) miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 13: 1353-1360.
30. Kim N, Kim H, Jung I, Kim Y, Kim D, et al. (2011) Expression profiles of miRNAs in human embryonic stem cells during hepatocyte differentiation. Hepatol Res 41: 170-183.
31. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S (2007) Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 101: 59-68.
32. Wang T, Xu Z (2010) miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun 402: 186-189.
33. Lin Q, Gao Z, Alarcon RM, Ye J, Yun Z (2009) A role of miR-27 in the regulation of adipogenesis. FEBS J 276: 2348-2358.
34. Lozano-Velasco E, Contreras A, Crist C, Hernandez-Torres F, Franco D, et al. (2011) Pitx2c modulates Pax3+/Pax7+ cell populations and regulates Pax3 expression by repressing miR27 expression during myogenesis. Dev Biol 357: 165-178.
35. Feng J, Iwama A, Satake M, Kohu K (2009) MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1. Br J Haematol 145: 412-423.
36. Myatt SS, Wang J, Monteiro LJ, Christian M, Ho KK, et al. (2010) Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res 70: 367-377.
37. Zhang Z, Liu S, Shi R, Zhao G (2011) miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genet 204: 486-491.
38. Piskounova E, Polytarchou C, Thornton JE, LaPierre RJ, Pothoulakis C, et al. (2011) Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell 147: 1066-1079.
39. Wagner RT, Xu X, Yi F, Merrill BJ, Cooney AJ (2010) Canonical Wnt/betacatenin regulation of liver receptor homolog-1 mediates pluripotency gene expression. Stem Cells 28: 1794-1804.
40. Jozefczuk J, Prigione A, Chavez L, Adjaye J (2011) Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation. Stem Cells Dev 20: 1259-1275.
41. Babaie Y, Herwig R, Greber B, Brink TC, Wruck W, et al. (2007) Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells 25: 500-510.
42. Andrews PW (1984) Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol 103: 285-293.
43. Zheng Y, Zhao YD, Gibbons M, Abramova T, Chu PY, et al. (2010) Tgfbeta signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2/3 and p38 MAPK. J Biol Chem 285: 35654-35664.
44. Mahmood A, Harkness L, Schroder HD, Abdallah BM, Kassem M (2010) Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542. J Bone Miner Res 25: 1216-1233.
45. Greber B, Lehrach H, Adjaye J (2008) Control of early fate decisions in human ES cells by distinct states of TGFbeta pathway activity. Stem Cells Dev 17: 1065-1077.
46. Hjelmeland MD, Hjelmeland AB, Sathornsumetee S, Reese ED, Herbstreith MH, et al. (2004) SB-431542, a small molecule transforming growth factor-betareceptor antagonist, inhibits human glioma cell line proliferation and motility. Mol Cancer Ther 3: 737-745.
47. Wong SS, Ritner C, Ramachandran S, Aurigui J, Pitt C, et al. (2012) miR-125b promotes early germ layer specification through Lin28/let-7d and preferential differentiation of mesoderm in human embryonic stem cells. PLoS One 7: E36121.
48. Miyazaki S, Yamamoto H, Miyoshi N, Takahashi H, Suzuki Y, et al. (2012) Emerging methods for preparing iPS cells. Jpn J Clin Oncol 42: 773-779.
49. Miyoshi N, Ishii H, Nagano H, Haraguchi N, Dewi DL, et al. (2011) Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8: 633-638.
50. Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, et al. (2011) Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23,27,24 clusters. Proc Natl Acad Sci U S A 108: 8287-8292.
51. Urbich C, Kaluza D, Fromel T, Knau A, Bennewitz K, et al. (2012) MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood 119: 1607-1616.
52. Chinchilla A, Lozano E, Daimi H, Esteban FJ, Crist C, et al. (2011) MicroRNA profiling during mouse ventricular maturation: A role for miR-27 modulating Mef2c expression. Cardiovasc Res 89: 98-108.
53. Kawasaki H, Taira K (2003) Hes1 is a target of microRNA-23 during retinoicacid-induced neuronal differentiation of NT2 cells. Nature 423: 838-842.
54. Zhang X, Yalcin S, Lee DF, Yeh TY, Lee SM, et al. (2011) FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat Cell Biol 13: 1092-1099.
55. Tang W, Zhu J, Su S, Wu W, Liu Q, et al. (2012) MiR-27 as a prognostic marker for breast cancer progression and patient survival. PLoS One 7: E51702.
56. Li L, Bennett SA, Wang L (2012) Role of E-cadherin and other cell adhesion molecules in survival and differentiation of human pluripotent stem cells. Cell Adh Migr 6: 59-70.
57. Chen T, Yuan D, Wei B, Jiang J, Kang J, et al. (2010) E-cadherin-mediated cellcell contact is critical for induced pluripotent stem cell generation. Stem Cells 28: 1315-1325.
58. Besser D (2004) Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J Biol Chem 279: 45076-45084.
59. Barroso-delJesus A, Lucena-Aguilar G, Sanchez L, Ligero G, Gutierrez-Aranda I, et al. (2011) The Nodal inhibitor Lefty is negatively modulated by the microRNA miR-302 in human embryonic stem cells. FASEB J 25: 1497-1508.
60. Du P, Kibbe WA, Lin SM (2008) lumi: A pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548.
61. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
62. Storey JD (2002) A direct approach to false discovery rates. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 64: 479-498.
63. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
64. Hay DC, Zhao D, Fletcher J, Hewitt ZA, McLean D, et al. (2008) Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo. Stem Cells 26: 894-902.